Compound information
- Natural Products
- ZC1373363
- Molecular Formula
- C18H21FN4O
- Molecular Weight
- 328.169939512 g/mol
- Structure
-
- IUPAC Name
- N-(3-fluoro-4-methyl-phenyl)-4-(3-pyridylmethyl)piperazine-1-carboxamide
- InChI
- InChI=1S/C18H21FN4O/c1-14-4-5-16(11-17(14)19)21-18(24)23-9-7-22(8-10-23)13-15-3-2-6-20-12-15/h2-6,11-12H,7-10,13H2,1H3,(H,21,24)
- InChI Key
- YLEDDJIZXQAUMZ-UHFFFAOYSA-N
- SMILES
- Cc1ccc(NC(=O)N2CCN(Cc3cccnc3)CC2)cc1F
- Source
- ZINC000013325069
Warheads
- Urea carbonyl
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 24 | Ring Count | 3 |
Heteroatom Count | 6 | Rotatable Bond Count | 3 |
Hydrogen Bond Acceptor Count | 3 | Hydrogen Bond Donor Count | 1 |
Topological Polar Surface Area | 48.47 Å2 | LogP | 2.296 |
LogS | -2.578 | LogD | 2.756 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.898 | Pgp substrate | 0.752 |
HIA | 0.965 | F20 % | 0.989 |
F30 % | 0.979 | Caco-2 | -4.868 |
MDCK | -4.851 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.386 | PPB | 85.749 |
VD | 1.285 | Fu | 0.645 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.089 | CYP1A2 substrate | 0.812 |
CYP2A6 substrate | 0.858 | CYP2B6 substrate | 0.743 |
CYP2C19 inhibitor | 0.75 | CYP2C19 substrate | 0.905 |
CYP2C8 substrate | 0.9 | CYP2C9 inhibitor | 0.687 |
CYP2C9 substrate | 0.987 | CYP2D6 inhibitor | 0.957 |
CYP2D6 substrate | 0.997 | CYP2E1 substrate | 0.917 |
CYP3A4 inhibitor | 0.539 | CYP3A4 substrate | 0.99 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.488 | CL | 11.922 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.542 | Hepatotoxicity | 0.928 |
Mutagenicity | 0.001 | Rat Oral Acute Toxicity | 0.822 |
FDAMDD | 0.566 | Skin Sensitization | 0.97 |
Carcinogenicity | 0.216 | Eye Corrosion | 0.002 |
Eye Irritation | 0.001 | Respiratory Toxicity | 0.957 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.63 | IGC50 | 2.53 |
LC50FM | -0.12 | LC50DM | -2.434 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.431 | NR-AR-LBD | 0.205 |
NR-AhR | 0.819 | NR-Aromatase | 0.038 |
NR-ER | 0.353 | NR-ER-LBD | 0.328 |
NR-PPAR-gamma | 0.149 | SR-ARE | 0.824 |
SR-ATAD5 | 0.337 | SR-HSE | 0.128 |
SR-MMP | 0.02 | SR-p53 | 0.07 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.